Entospletinib. Spleen tyrosine kinase (SYK) inhibitor, Hematological cancer therapy
-
Published:2022
Issue:2
Volume:47
Page:99
-
ISSN:0377-8282
-
Container-title:Drugs of the Future
-
language:en
-
Short-container-title:Drugs Fut
Author:
Wei Z-H.,Koya J.,Dong X-D.,Reznik S.E.,Chen Z.-S.
Subject
Pharmacology (medical),Pharmacology